Complexa lands $62 mln Series C
Pennsylvania-based Complexa Inc, a clinical stage biopharmaceutical company, has closed $62 million in Series C funding. New Enterprise Associates and Pfizer Venture Investments LLC led the round with participation from other investors that included Edmond de Rothschild Investment Partners and HBM Healthcare Investments.
26 July 2017•1 min read
